Pharm Flashcards
(35 cards)
what is the combination treatment for ALL (combination tx is used b/c of resistance)
vincristine + prednisone + ________ (6-MP, cyclophosphamide, or daunorubicin)
most active agent for AML
cytarabine
best combo tx for AML
cytarabine + idarubicin
combo tx for AML is followed by ______
high-dose chemo and total body irradiation followed by immunosuprression
3 first line treatments for chronic phase CML
imatibin, dasatibin, nilotinib
besides the first line tx for CML imatibin, dasatibin, nilotinib, what other drug can be used
busulfan
two regimens for CLL
COP: cyclophosphamide + vincristine + prednisone
CHOP: cyclophosphamide + vincristine + prednisone + doxorubicin
besides COP and CHOP, what agents can be used for CLL
bendamustine (monotherapy or w/ prednisone)
fludarabine (monotherapy or w/ cyclophosphamide and mitoxantrone)
regimen for hodgkin’s lymphoma stage I and IIa
ABVD - doxorubicin, bleomycin, vinblastine, dacarbazine
regimen for hodgkin’s lymphoma stage III and IV
MOPP: mechlorethamine, vincristine, procarbazine, prednisone
ABVD: doxorubicin, bleomycin, vinblastine, dacarbazine
Stanford V: doxorubicin, vinblastine, mechlorethamine, vincristine, bleomycin, etoposide, prednisone
compare MOPP, ABVD, and stanford V regimens for hodgkin’s lymphoma III and IV
ABVD: more effective and less toxic than MOPP
stanford V: middle best
MOPP: most adverse effects
regimen for diffuse non-hodgkin’s lymphoma
CHOP: cyclophosphamide, doxorubicin, vincristine, prednisone
regimen for nodular (follicular) non-hodgkin’s lymphoma
bendamustine
regimen for multiple myeloma
melphalan + prednisone
treatment for stage 1 breast cancer
surgery alone
treatment for stage 2 breast cancer
post-operative:
CMF: cyclophosphamide, methotrexate, 5-FU
FAC: 5-FU, doxorubicin, cyclophosphamide
treatment for hormone refractory prostate CA
docetaxel + prednisone
regimens for high risk stage II and III colorectal CA
FOLFOX: leucovorin + 5-FU + oxaliplatin
XELOX: capecitabine + oxaliplatin
regimens for metastatic colorectal cancer
FOLFIRI: leucovorin + 5-FU + irinotecan
FOLFIRI or FOLFOX + bevacizumab or cetuximab/panitumumab
what agent do you use for chemo-refractory setting of colorectal cancer
TAS-102
standard treatment for non-small cell lung CA with non-squamous histology
bevacizumab + carboplatin + paclitaxel
treatment for non-small cell lung CA with squamous cell histology
cisplatin or carboplatin + cetuximab
agent used for maintenance chemotherapy in non-small cell lung CA
pemetrexed
targeted therapy for non-small cell lung CA pts with sensitizing EGFR mutations
first line tx for metastatic NSCLC w/ EGFR mutations
tx for metastatic NSCLC w/ EGFR T790 mutations
erlotinib
afatinib
osimertinib